Significant Updates on Neoadjuvant Treatments for Stage 3 Melanoma
Marco Donia moderated a press conference on immunotherapy at ESMO 2024. In this MEDtalk, he discusses significant updates on neoadjuvant treatments for stage 3 melanoma, where immunotherapy before surgery improves outcomes, mainly when a significant pathological response is achieved.